Ketamine Therapy for Social Anxiety
Social anxiety disorder is not shyness. It is a recognized psychiatric condition in which fear of social situations produces significant distress and functional impairment, and it is one of the most common anxiety disorders in the United States. For many people, first line treatments provide meaningful relief. For others, the fear persists through therapy, through medication trials, and through years of effort. Social anxiety ketamine therapy is one option that some patients with treatment resistant presentations eventually consider, and this page explains it in clinical terms, including what the evidence does and does not support.
Allay Health and Wellness offers ketamine therapy for anxiety in Palm Beach Gardens, Florida, as an off label clinical service for adults who have not found adequate relief through standard care. This page covers what social anxiety disorder is, why standard treatments sometimes fall short, where social anxiety ketamine therapy fits in the treatment landscape, what the research shows, and who may be an appropriate candidate for evaluation.
What Social Anxiety Disorder Actually Involves
Social anxiety disorder, also called social phobia, is characterized by intense fear of social situations in which the person may be observed or judged negatively by others. It extends to ordinary interactions: meeting new people, eating in front of others, speaking in a group, even making phone calls.
The National Institute of Mental Health identifies social anxiety disorder as one of the most prevalent anxiety disorders in the United States, with onset typically in adolescence and a course that, without treatment, tends to persist into adulthood. The functional impact is significant. Careers are shaped around avoidance. Relationships remain shallow because depth requires vulnerability. People know their fear is disproportionate but cannot act on that knowledge when the moment arrives. That gap between what you understand and what your body does is the illness, and it is also part of why some patients eventually research social anxiety ketamine therapy after years of cognitive work that moved the needle only partially.
Social anxiety carries high rates of co occurrence with major depressive disorder, generalized anxiety disorder, and alcohol use disorder. Our ketamine therapy for anxiety covers the broader anxiety treatment landscape, and our addiction recovery program serves patients whose anxiety and substance use are intertwined.
Why Standard Treatments Sometimes Fall Short
For most patients with social anxiety disorder, the established first line treatments are genuinely effective. Cognitive behavioral therapy adapted for social anxiety, particularly with a structured exposure component, has the strongest evidence base of any intervention for this condition. SSRIs and SNRIs, including paroxetine, sertraline, and venlafaxine, all of which carry FDA approval for social anxiety disorder, help a significant portion of patients. The American Psychological Association maintains clinical guidance on anxiety treatment relevant to any prescribing discussion.
For patients who respond adequately to these approaches, that is where they belong. Social anxiety ketamine therapy is not a shortcut past first line care, and we will say so directly if a patient comes to us before exhausting those options. Social anxiety ketamine therapy is for patients who have genuinely attempted standard treatments at adequate doses and durations and have not achieved sufficient relief.
The reasons first line treatments fail for some patients are not fully understood. For patients whose anxiety circuits do not respond adequately to serotonin and norepinephrine targeting medications, a treatment acting on a different neurobiological system represents a genuine clinical rationale, which is part of what motivates interest in social anxiety ketamine therapy at a mechanistic level.
Off Label Ketamine for Social Anxiety: What the Evidence Shows
This must be stated precisely from the start. Social anxiety ketamine therapy is an off label use of ketamine. The FDA has not approved IV ketamine for social anxiety disorder, for any anxiety disorder, or for any psychiatric condition. Its only approved indication is as a general anesthetic.
Spravato (esketamine) is not approved for social anxiety disorder either. Its two FDA approved indications are treatment resistant depression in adults used alongside an oral antidepressant, and depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior. Neither indication includes social anxiety, and Spravato is not used at Allay Health and Wellness for this condition. The evidence base for social anxiety ketamine therapy is meaningful but genuinely early, and any clinic presenting social anxiety ketamine therapy as well established is overstating what the literature currently supports. Most research examining ketamine’s anxiolytic effects has studied anxiety as a secondary outcome measure in depression trials, or has used smaller sample sizes without the placebo controlled design that establishes the strongest evidence. A 2022 review in Frontiers in Psychiatry examining ketamine across anxiety disorders found that while rapid and clinically significant reductions in anxiety symptoms have been observed, larger controlled trials specific to social anxiety disorder are needed before definitive conclusions can be drawn.
What the mechanism suggests is clinically plausible. Social anxiety disorder involves dysfunction in circuits governing threat appraisal and social evaluation, particularly the amygdala and prefrontal cortex. Ketamine’s action on the glutamate system through NMDA receptor modulation may influence these circuits differently than SSRIs and SNRIs do, which is a genuine clinical rationale rather than an arbitrary next option. The neurobiological explanation for how ketamine affects anxiety circuits is covered in more depth at how ketamine for anxiety works. Patients considering social anxiety ketamine therapy should understand that the evidence for this specific condition is less developed than for treatment resistant depression. This is not a reason to avoid evaluation, but it is a fact that any honest provider offering social anxiety ketamine therapy states upfront, because realistic expectations shape how patients interpret and engage with their own response.
Social Anxiety and the Dissociation Question
This deserves its own section for patients with social anxiety disorder specifically, because it does not come up the same way for other presentations. Ketamine produces a dissociative state during infusions: a temporary altered perception of time, space, and self. For many patients this effect is manageable, and some find it genuinely settling. But patients with social anxiety disorder often have a particular relationship to internal physiological monitoring that is worth addressing directly before the first session.
Social anxiety frequently involves what researchers call interoceptive hyperawareness, a heightened tendency to notice and interpret internal physical states. A racing heart in a social situation reads as evidence that others are noticing you failing. Translated into a ketamine session, an unfamiliar internal state can be interpreted as something going wrong even when it is not.
This does not mean patients with social anxiety cannot tolerate social anxiety ketamine therapy sessions. Many do, and with appropriate preparation most people report the experience as more manageable than they anticipated. It does mean that preparation before sessions matters more for this population than for some others. Our ketamine assisted therapy in Florida model, which pairs infusions with structured clinical preparation and integration work rather than delivering them alone, is particularly relevant for social anxiety presentations. A frank and detailed account of what infusion sessions actually feel like is at what ketamine infusions are really like, and patients with social anxiety evaluating treatment often find it useful reading before their first consultation.
How Ketamine and Therapy Work Together for Social Anxiety
For social anxiety disorder, the relationship between social anxiety ketamine therapy and ongoing psychotherapy deserves specific attention. Exposure based cognitive behavioral therapy is the most evidence supported long term intervention for this condition. The mechanism is behavioral: repeated, graduated exposure to feared social situations, without the avoidance response, gradually retrains the threat appraisal circuits that maintain the anxiety.
The clinical question is whether ketamine can support that process. One hypothesis, which has some support in the broader anxiety and PTSD literature, is that ketamine’s effects on neuroplasticity may open a window during which exposure work becomes more accessible. If anxiety intensity is reduced following infusions, the feared social situations may feel more approachable, making it possible to complete the exposure tasks that had previously been too activating to attempt. This is why patients pursuing social anxiety ketamine therapy are encouraged to maintain engagement with an exposure focused therapist throughout treatment. Ketamine is most defensible as a complement to that work, not a replacement for it. Our ketamine assisted therapy in Florida program is built around this integration model, and how ketamine therapy fits into a comprehensive mental health plan explains the broader rationale.
Who May Be a Candidate
A clinical evaluation is required before any treatment recommendation is made. Adults who may be appropriate candidates for social anxiety ketamine therapy at Allay Health and Wellness typically present with the following:
A formal social anxiety disorder diagnosis from a licensed clinician, with documented inadequate response to at least two evidence based treatments at adequate doses. Current engagement with exposure based psychotherapy alongside infusion treatment. Absence of medical contraindications including uncontrolled hypertension or active psychosis. Substance use history is evaluated carefully because ketamine is a Schedule III controlled substance. Elevated alcohol use rates in this population make this an especially important part of intake. A substance use history does not automatically disqualify anyone but is a clinically significant factor.
Allay Health and Wellness treats adult patients 18 years and older exclusively. Our ketamine therapy FAQ addresses common pre evaluation questions, and who is eligible for ketamine therapy covers the eligibility picture across anxiety and related presentations.
What Treatment Involves at Allay
- Evaluation. The intake for social anxiety ketamine therapy covers your diagnosis, full treatment history including every medication and therapy attempted with doses and durations, current medications, cardiovascular health, substance use history, and current mental health support. No referral is required. Bring your complete clinical record for a more productive evaluation.
- The sessions. IV ketamine is given slowly through an intravenous line in a private, monitored room. A licensed clinician tracks vital signs continuously throughout every session. A standard initial course for social anxiety ketamine therapy involves six infusions over two to three weeks, with maintenance based on clinical response. How many ketamine therapy sessions are usually needed gives a realistic picture of what the treatment arc typically looks like.
- After sessions. You may not drive on the day of any infusion. A responsible adult must arrange transportation home.
Risks and Side Effects
Every patient evaluated for social anxiety ketamine therapy receives a full risk disclosure before anything is scheduled.
- Dissociation is a temporary altered state expected at therapeutic doses. Clinical staff remain present throughout every session specifically to provide support if the experience becomes difficult.
- Sedation means no driving the day of any session.
- Blood pressure changes are common and temporary. Vital signs are monitored before, during, and after every session.
- Nausea and dizziness are generally mild and typically resolve fully during the post session observation period before discharge.
- Psychological effects. Some patients experience heightened emotional intensity during sessions. Clinical staff are present throughout every infusion.
- Controlled substance status. Ketamine is Schedule III federally. Dependency risk at supervised therapeutic doses is considered low but not zero. This is addressed honestly and directly at whether ketamine is addictive.
No outcome from social anxiety ketamine therapy is guaranteed. Individual responses vary substantially, and given that the evidence base for this condition specifically remains earlier stage than for treatment resistant depression, patients who understand that going in are better positioned to evaluate their own response honestly.
If You Are in Crisis
Social anxiety ketamine therapy at Allay Health and Wellness is a planned, scheduled clinical service. It is not emergency care. If you or someone you know is experiencing a mental health emergency or thoughts of suicide, call or text 988, call 911, or go to the nearest emergency room. SAMHSA’s National Helpline is available free and confidential at 1-800-662-4357.
Frequently Asked Questions About Ketamine Therapy for Social Anxiety Disorder
- Is ketamine approved for social anxiety disorder?
No. Social anxiety ketamine therapy is an off label use. The FDA has not approved IV ketamine for any anxiety disorder or psychiatric condition. Spravato is not approved for social anxiety either. CBT with exposure and SSRIs or SNRIs remain the recommended first line treatments. - Will ketamine make it easier to be in social situations?
Some patients with anxiety disorders report reduced anxiety intensity following ketamine infusions, though individual responses vary and no specific outcome is guaranteed. Social anxiety ketamine therapy is not an as needed medication taken before social events. It is a supervised clinical treatment given in a medical setting over a course of infusions, not a situational anxiolytic. - How is the dissociation managed for someone with social anxiety?
Preparation before the first session covers what the dissociative state involves, what to expect physically, and how to orient yourself if it feels unfamiliar. Clinical staff remain present throughout. Many patients with social anxiety find the experience more manageable than anticipated. Some find it challenging. Both are discussed honestly before you commit to anything. - Does insurance cover social anxiety ketamine therapy?
Off label IV ketamine is generally not covered by most insurance plans. Allay accepts Medicare, Cigna, United Healthcare, and Aetna for eligible services. Our team verifies benefits and provides a cost summary before any sessions are scheduled. Coverage is never guaranteed and varies by individual plan. - Should I be in therapy while receiving ketamine treatment?
For social anxiety disorder specifically, we consider ongoing engagement with exposure based therapy important, not merely recommended. Ketamine may reduce anxiety intensity in ways that make exposure work more tolerable, but the exposure still has to happen. The evidence for social anxiety consistently points to behavioral change as the path to durable improvement. - Do I need a referral?
No referral is required. We encourage patients to bring documentation of their diagnosis, full medication history with doses and durations, and a description of therapy approaches completed.
Schedule a Consultation for Social Anxiety Disorder Treatment
If standard treatments for social anxiety disorder have not provided the relief you need, and you want a clinical team that will evaluate your situation honestly, Allay Health and Wellness is ready to have that conversation. Our team credentials are on our team resource. Our mental health resource covers the full range of what we treat. Our scholarly resources link directly to peer reviewed literature. Allay Health and Wellness treats adult patients 18 years and older exclusively.
Allay Health and Wellness
11000 Prosperity Farms Rd, Suite 101 Palm Beach Gardens, FL 33410
Reach us through our contact resource.
Medical Disclaimer: This content is educational only and not a substitute for professional medical advice, diagnosis, or treatment. IV ketamine for social anxiety disorder is an off-label use, not FDA-approved for any anxiety disorder or psychiatric condition. Spravato is not approved for social anxiety. CBT with exposure and SSRIs or SNRIs remain recommended first-line treatments. Individual outcomes vary and are never guaranteed. Treatment requires evaluation by a licensed clinician. Allay treats adults 18 and older.

